semaglutide 1.34 Ozempic 2 mg/1.5 mL (1.34 mg/mL) prefilled pen that delivers 0.25 mg or 0.5 mg per injection Images File:Wegovy - Semaglutide.jpg - Wikimedia

2016;11(11):e0163716

This has opened new avenues for treatment, as weight management is a critical component of overall health and can help mitigate the risk of developing other chronic conditions

Clinical trials have demonstrated that Wegovy, when used alongside lifestyle modifications, can result in an average weight loss of approximately 15% of initial body weight over 68 weeks, as reported in the STEP 1 trial and referenced in NICE technology appraisal guidance (TA875)

Whether that gain holds up against retatrutide's already-stronger backbone is the open empirical question additive effects often diminish as the base compound's efficacy increases

[ Editors note: Vyleesi is a melanocortin receptor agonist indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire